---
layout: post
title: "维亚生物暴涨37% 子公司获授权免费仿制默沙东口服新冠药molnupiravir"
date: 2022-01-21 09:34:57 +0800
categories: emnews
tags: 东财滚动新闻
---
> 维亚生物(1873.HK)盘初拉升暴涨超37%报5.55港元，最新市值107亿港元。消息面上，维亚生物子公司朗华制药获授权免费仿制默沙东口服COVID-19抗病毒药物molnupiravir。

<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01873" data-code="01873|116|5" data-code2="01873|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.01873&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 01873_0" data-code="K 01873|116|5" data-code2="K 01873|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p><span id="Info.116.01873"><a href="http://quote.eastmoney.com/unify/r/116.01873" class="keytip" data-code="116,01873">维亚生物</a></span>(1873.HK)盘初拉升暴涨超37%报5.55港元，最新市值107亿港元。<br /></p>
 <p>消息面上，<span web="1" href="http://quote.eastmoney.com/unify/r/116.01873" class="em_stock_key_common" data-code="116,01873">维亚生物</span>子公司朗华制药获授权免费仿制<span id="stock_106.MRK"><a href="http://quote.eastmoney.com/unify/r/106.MRK" class="keytip" data-code="106,MRK">默沙东</a></span><span id="quote_106.MRK"></span>口服COVID-19抗病毒药物molnupiravir。</p><p class="em_media">（文章来源：格隆汇）</p>

<http://hk.eastmoney.com/news/1533,202201212256046858.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)